CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.

International journal of oncology

Volumn 16, Issue 1, 2000, Pages 149-154

  Lorusso, V ^a   Palmieri, G ^a   Bianco, A R ^a   Abate, G ^a   Catalano, G ^a   De Vita, F ^a   Dammacco, F ^a   Lauta, V M ^a   Lucarelli, G ^a   Polimeno, G ^a   Mantovani, G ^a   D'Aprile, M ^a   Marzullo, F ^a   De Lena, M ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CEOP B PROTOCOL; CEOP-B PROTOCOL; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; PROMACE CYTABOM PROTOCOL; PROMACE-CYTABOM PROTOCOL; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM STAGING; PREDNISONE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

MLCS; MLOWN;

EID: 0033628343     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.16.1.149     Document Type: Article

References (0)